{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:43:59Z","timestamp":1792593839824,"version":"4.5.0"},"reference-count":50,"publisher":"MyJove Corporation","issue":"224","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68827","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:01:40Z","timestamp":1760137300000},"source":"Crossref","is-referenced-by-count":0,"title":["Expression, Clinical Significance, and Role in Immunotherapy Efficacy Evaluation of the Co-stimulatory Molecule LLT1 in Gastric Cancer"],"prefix":"10.3791","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqin","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"3","key":"ref1","first-page":"229","type":"journal-article","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74 (3), 229-263 (2024).","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cgh.2022.07.029","type":"journal-article","article-title":"Long-term survival after endoscopic resection for gastric cancer: Real-world evidence from a multicenter prospective cohort","volume":"21","author":"Suzuki","year":"2023","unstructured":"Suzuki, H. et al. Long-term survival after endoscopic resection for gastric cancer: Real-world evidence from a multicenter prospective cohort. Clin Gastroenterol Hepatol. 21 (2), 307-318.e2 (2023).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-023-01715-z","type":"journal-article","article-title":"Clinical application and detection techniques of liquid biopsy in gastric cancer","volume":"22","author":"Ma","year":"2023","unstructured":"Ma, S. et al. Clinical application and detection techniques of liquid biopsy in gastric cancer. Mol Cancer. 22 (1), 7 (2023).","journal-title":"Mol Cancer"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","type":"journal-article","article-title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","volume":"19","author":"Ugai","year":"2022","unstructured":"Ugai, T. et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 19 (10), 656-673 (2022).","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"ref5","first-page":"Cd004064","type":"journal-article","article-title":"Chemotherapy for advanced gastric cancer","volume":"8","author":"Wagner","year":"2017","unstructured":"Wagner, A. D. et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 8 (8), Cd004064 (2017).","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","type":"journal-article","article-title":"Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the keynote-059, keynote-061, and keynote-062 clinical trials","volume":"7","author":"Chao","year":"2021","unstructured":"Chao, J. et al. Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the keynote-059, keynote-061, and keynote-062 clinical trials. JAMA Oncol. 7 (6), 895-902 (2021).","journal-title":"JAMA Oncol"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-22-0121","type":"journal-article","article-title":"Association of tumor mutational burden with efficacy of pembrolizumab\u00b1chemotherapy as first-line therapy for gastric cancer in the phase III Keynote-062 study","volume":"28","author":"Lee","year":"2022","unstructured":"Lee, K. W. et al. Association of tumor mutational burden with efficacy of pembrolizumab\u00b1chemotherapy as first-line therapy for gastric cancer in the phase III Keynote-062 study. Clin Cancer Res. 28 (16), 3489-3498 (2022).","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-20-2980","type":"journal-article","article-title":"Efficacy of pembrolizumab monotherapy for advanced gastric\/gastroesophageal junction cancer with programmed death ligand 1 combined positive score \u226510","volume":"27","author":"Wainberg","year":"2021","unstructured":"Wainberg, Z. A. et al. Efficacy of pembrolizumab monotherapy for advanced gastric\/gastroesophageal junction cancer with programmed death ligand 1 combined positive score \u226510. Clin Cancer Res. 27 (7), 1923-1931 (2021).","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.21.01862","type":"journal-article","article-title":"Low programmed death-ligand 1-expressing subgroup outcomes of first-line immune checkpoint inhibitors in gastric or esophageal adenocarcinoma","volume":"40","author":"Zhao","year":"2022","unstructured":"Zhao, J. J. et al. Low programmed death-ligand 1-expressing subgroup outcomes of first-line immune checkpoint inhibitors in gastric or esophageal adenocarcinoma. J Clin Oncol. 40 (4), 392-402 (2022).","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"101206","DOI":"10.1016\/j.drup.2025.101206","type":"journal-article","article-title":"Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy","volume":"79","author":"Zhu","year":"2025","unstructured":"Zhu, Q., Zhang, R., Zhao, Z., Xie, T., Sui, X. Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy. Drug Resist Updat. 79, 101206 (2025).","journal-title":"Drug Resist Updat"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","type":"journal-article","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","unstructured":"Khosravi, G. R. et al. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun (Lond). 44 (5), 521-553 (2024).","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","type":"journal-article","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","unstructured":"Gibney, G. T., Weiner, L. M., Atkins, M. B. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 17 (12), e542-e551 (2016).","journal-title":"Lancet Oncol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","type":"journal-article","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A., Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 168 (4), 707-723 (2017).","journal-title":"Cell"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/annonc\/mdw141","type":"journal-article","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"27","author":"Naidoo","year":"2016","unstructured":"Naidoo, J. et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol. 27 (7), 1362 (2016).","journal-title":"Ann Oncol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"pbae020","DOI":"10.1093\/pcmedi\/pbae020","type":"journal-article","article-title":"Novel immunotherapeutic approaches in gastric cancer","volume":"7","author":"Yang","year":"2024","unstructured":"Yang, M., Lin, W., Huang, J., Mannucci, A., Luo, H. Novel immunotherapeutic approaches in gastric cancer. Precis Clin Med. 7 (4), pbae020 (2024).","journal-title":"Precis Clin Med"},{"issue":"46","key":"ref16","doi-asserted-by":"crossref","first-page":"36207","DOI":"10.1074\/jbc.M110.179622","type":"journal-article","article-title":"Characterization of alternatively spliced transcript variants of clec2d gene","volume":"285","author":"Germain","year":"2010","unstructured":"Germain, C. et al. Characterization of alternatively spliced transcript variants of clec2d gene. J Biol Chem. 285 (46), 36207-36215 (2010).","journal-title":"J Biol Chem"},{"issue":"1-2","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002510050679","type":"journal-article","article-title":"Cloning of a new lectin-like receptor expressed on human NK cells","volume":"50","author":"Boles","year":"1999","unstructured":"Boles, K. S., Barten, R., Kumaresan, P. R., Trowsdale, J., Mathew, P. A. Cloning of a new lectin-like receptor expressed on human NK cells. Immunogenetics. 50 (1-2), 1-7 (1999).","journal-title":"Immunogenetics"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.4049\/jimmunol.175.12.7796","type":"journal-article","article-title":"Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human nkr-p1a receptor","volume":"175","author":"Rosen","year":"2005","unstructured":"Rosen, D. B. et al. Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human nkr-p1a receptor. J Immunol. 175 (12), 7796-7799 (2005).","journal-title":"J Immunol"},{"issue":"44","key":"ref19","doi-asserted-by":"crossref","first-page":"37964","DOI":"10.1074\/jbc.M111.285312","type":"journal-article","article-title":"Induction of lectin-like transcript 1 (llt1) protein cell surface expression by pathogens and interferon-\u03b3 contributes to modulate immune responses","volume":"286","author":"Germain","year":"2011","unstructured":"Germain, C. et al. Induction of lectin-like transcript 1 (llt1) protein cell surface expression by pathogens and interferon-\u03b3 contributes to modulate immune responses. J Biol Chem. 286 (44), 37964-37975 (2011).","journal-title":"J Biol Chem"},{"issue":"6","key":"ref20","first-page":"1050","type":"journal-article","article-title":"Blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells","volume":"8","author":"Marrufo","year":"2018","unstructured":"Marrufo, A. M. et al. Blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells. Am J Cancer Res. 8 (6), 1050-1063 (2018).","journal-title":"Am J Cancer Res"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"e1026503","DOI":"10.1080\/2162402X.2015.1026503","type":"journal-article","article-title":"Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas, dampening natural killer cell functions","volume":"4","author":"Germain","year":"2015","unstructured":"Germain, C. et al. Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas, dampening natural killer cell functions. Oncoimmunology. 4 (8), e1026503 (2015).","journal-title":"Oncoimmunology"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-06-4783","type":"journal-article","article-title":"Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1","volume":"67","author":"Roth","year":"2007","unstructured":"Roth, P. et al. Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1. Cancer Res. 67 (8), 3540-3544 (2007).","journal-title":"Cancer Res"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/biomedicines8120535","type":"journal-article","article-title":"Lectin-like transcript 1 (llt1) checkpoint: A novel independent prognostic factor in hpv-negative oropharyngeal squamous cell carcinoma","volume":"8","author":"Sanchez-Canteli","year":"2020","unstructured":"Sanchez-Canteli, M. et al. Lectin-like transcript 1 (llt1) checkpoint: A novel independent prognostic factor in hpv-negative oropharyngeal squamous cell carcinoma. Biomedicines. 8 (12), 535 (2020).","journal-title":"Biomedicines"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"e1423184","DOI":"10.1080\/2162402X.2017.1423184","type":"journal-article","article-title":"Expression of llt1 and its receptor CD161 in lung cancer is associated with better clinical outcome","volume":"7","author":"Braud","year":"2018","unstructured":"Braud, V. M. et al. Expression of llt1 and its receptor CD161 in lung cancer is associated with better clinical outcome. Oncoimmunology. 7 (5), e1423184 (2018).","journal-title":"Oncoimmunology"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","type":"journal-article","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis","volume":"184","author":"Mathewson","year":"2021","unstructured":"Mathewson, N. D. et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 184 (5), 1281-1298.e26 (2021).","journal-title":"Cell"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"e14663","DOI":"10.1097\/MD.0000000000014663","type":"journal-article","article-title":"Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis","volume":"98","author":"Guo","year":"2019","unstructured":"Guo, L. et al. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis. Medicine (Baltimore). 98 (8), e14663 (2019).","journal-title":"Medicine (Baltimore)"},{"issue":"48","key":"ref27","doi-asserted-by":"crossref","first-page":"e36323","DOI":"10.1097\/MD.0000000000036323","type":"journal-article","article-title":"Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment","volume":"102","author":"Quan","year":"2023","unstructured":"Quan, Q. et al. Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment. Medicine (Baltimore). 102 (48), e36323 (2023).","journal-title":"Medicine (Baltimore)"},{"key":"ref28","first-page":"100039","type":"journal-article","article-title":"Morphometric image analysis of placental c-type lectin domain family 2, member d (clec2d) immuno-expression in hiv associated pre-eclampsia","volume":"3","author":"Varaden","year":"2019","unstructured":"Varaden, D., Moodley, J., Onyangunga, O. A., Naicker, T. Morphometric image analysis of placental c-type lectin domain family 2, member d (clec2d) immuno-expression in hiv associated pre-eclampsia. Eur J Obstet Gynecol Reprod Biol X. 3, 100039 (2019).","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"issue":"18","key":"ref29","doi-asserted-by":"crossref","first-page":"16609","DOI":"10.1007\/s00432-023-05408-4","type":"journal-article","article-title":"B7-h3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy","volume":"149","author":"Chen","year":"2023","unstructured":"Chen, S. et al. B7-h3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy. J Cancer Res Clin Oncol. 149 (18), 16609-16621 (2023).","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7517","key":"ref30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","type":"journal-article","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 513 (7517), 202-209 (2014).","journal-title":"Nature"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","type":"journal-article","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","unstructured":"Cristescu, R. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 21 (5), 449-456 (2015).","journal-title":"Nat Med"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","type":"journal-article","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity. 48 (4), 812-830.e814 (2018).","journal-title":"Immunity"},{"issue":"7528","key":"ref33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","type":"journal-article","article-title":"Pd-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. Pd-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 515 (7528), 568-571 (2014).","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-024-00984-x","type":"journal-article","article-title":"Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: A multidimensional approach","author":"Lopez De Rodas","year":"2025","unstructured":"Lopez De Rodas, M. et al. Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: A multidimensional approach. Nat Rev Clin Oncol. 10.1038\/s41571-024-00984-x (2025).","journal-title":"Nat Rev Clin Oncol"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-334026","type":"journal-article","article-title":"Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab","author":"Myojin","year":"2025","unstructured":"Myojin, Y. et al. Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab. Gut. 10.1136\/gutjnl-2024-334026 (2025).","journal-title":"Gut"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","type":"journal-article","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: Expect the unexpected","volume":"125","author":"Marvel","year":"2015","unstructured":"Marvel, D. Gabrilovich, D. I. Myeloid-derived suppressor cells in the tumor microenvironment: Expect the unexpected. J Clin Invest. 125 (9), 3356-3364 (2015).","journal-title":"J Clin Invest"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","type":"journal-article","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman, C., Petitprez, F., Calderaro, J., Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 19 (6), 307-325 (2019).","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","type":"journal-article","article-title":"Gastric cancer-derived exosomal let-7 g-5p mediated by serpine1 promotes macrophage m2 polarization and gastric cancer progression","volume":"44","author":"Ye","year":"2025","unstructured":"Ye, Z. et al. Gastric cancer-derived exosomal let-7 g-5p mediated by serpine1 promotes macrophage m2 polarization and gastric cancer progression. J Exp Clin Cancer Res. 44 (1), 2 (2025).","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","type":"journal-article","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","unstructured":"Gajewski, T. F., Schreiber, H., Fu, Y. X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 14 (10), 1014-1022 (2013).","journal-title":"Nat Immunol"},{"issue":"6013","key":"ref40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","type":"journal-article","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","unstructured":"Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science. 331 (6013), 44-49 (2011).","journal-title":"Science"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","type":"journal-article","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","unstructured":"Xiong, S., Dong, L., Cheng, L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 14 (1), 173 (2021).","journal-title":"J Hematol Oncol"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/ATVBAHA.113.300168","type":"journal-article","article-title":"Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: Lessons and open questions","volume":"33","author":"Mantovani","year":"2013","unstructured":"Mantovani, A., Locati, M. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: Lessons and open questions. Arterioscler Thromb Vasc Biol. 33 (7), 1478-1483 (2013).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","type":"journal-article","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","unstructured":"Niu, X. et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat. 78, 101170 (2025).","journal-title":"Drug Resist Updat"},{"issue":"8049","key":"ref44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","type":"journal-article","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","unstructured":"Ikeda, H. et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature. 638 (8049), 225-236 (2025).","journal-title":"Nature"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","type":"journal-article","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","unstructured":"Gabrilovich, D. I. Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 9 (3), 162-174 (2009).","journal-title":"Nat Rev Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1192303","DOI":"10.3389\/fimmu.2023.1192303","type":"journal-article","article-title":"The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment","volume":"14","author":"Pan","year":"2023","unstructured":"Pan, Y. et al. The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment. Front Immunol. 14, 1192303 (2023).","journal-title":"Front Immunol"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","type":"journal-article","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","unstructured":"Smyth, M. J. et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 192 (5), 755-760 (2000).","journal-title":"J Exp Med"},{"issue":"5795","key":"ref48","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","type":"journal-article","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","unstructured":"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313 (5795), 1960-1964 (2006).","journal-title":"Science"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","type":"journal-article","article-title":"Approaches to treat immune hot, altered, and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","unstructured":"Galon, J., Bruni, D. Approaches to treat immune hot, altered, and cold tumours with combination immunotherapies. Nat Rev Drug Discov. 18 (3), 197-218 (2019).","journal-title":"Nat Rev Drug Discov"},{"issue":"7637","key":"ref50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","type":"journal-article","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","unstructured":"Chen, D. S., Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature. 541 (7637), 321-330 (2017).","journal-title":"Nature"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68827\/expression-clinical-significance-role-immunotherapy-efficacy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:24:00Z","timestamp":1792592640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68827\/expression-clinical-significance-role-immunotherapy-efficacy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":50,"journal-issue":{"issue":"224","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68827","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}